20/11/2018 (Agence Europe) – On Tuesday 20 November, the European Commission conditionally approved the acquisition of Shire plc (Shire) by Takeda Pharmaceutical Company Limited (Takeda). The two pharmaceutical companies operating in the European Economic Area market notified the institution of their proposed transaction on 28 September. During their investigation, they focused on biological treatments for inflammatory bowel disease (IBD), with Takeda now offering a type of...